Haemonetics Total Assets 2006-2018 | HAE

Haemonetics total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Haemonetics Annual Total Assets
(Millions of US $)
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
2008 $609
2007 $573
2006 $545
2005 $468
Haemonetics Quarterly Total Assets
(Millions of US $)
Q3 2018 $1,228
Q2 2018 $1,266
Q1 2018 $1,241
Q4 2018 $1,237
Q3 2017 $1,312
Q2 2017 $1,271
Q1 2017 $1,251
Q4 2017 $1,239
Q3 2016 $1,306
Q2 2016 $1,335
Q1 2016 $1,317
Q4 2016 $1,319
Q3 2015 $1,336
Q2 2015 $1,419
Q1 2015 $1,427
Q4 2015 $1,485
Q3 2014 $1,474
Q2 2014 $1,475
Q1 2014 $1,477
Q4 2014 $1,514
Q3 2013 $1,488
Q2 2013 $1,484
Q1 2013 $1,480
Q4 2013 $1,462
Q3 2012 $1,474
Q2 2012 $1,455
Q1 2012 $928
Q4 2012 $911
Q3 2011 $848
Q2 2011 $824
Q1 2011 $853
Q4 2011 $833
Q3 2010 $783
Q2 2010 $738
Q1 2010 $698
Q4 2010 $761
Q3 2009 $702
Q2 2009 $714
Q1 2009 $692
Q4 2009 $650
Q3 2008 $622
Q2 2008 $601
Q1 2008 $608
Q4 2008 $609
Q3 2007 $566
Q2 2007 $549
Q1 2007 $578
Q4 2007 $573
Q3 2006 $550
Q2 2006 $561
Q1 2006 $568
Q4 2006 $545
Q3 2005 $523
Q2 2005 $499
Q1 2005 $486
Q4 2005 $468
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.354B $0.904B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00